Notably, transgenic mice with overexpression of INGAP are resistant to the diabetogenic action of streptozotocin (STZ), which improves oral glucose tolerance and delays the onset of diabetes (9, 21). The gene discussed is REG3A; the disease is diabetes mellitus.